NCT03515096
- Conditions
- Blood Platelet Disorders, Cytopenia, Eltrombopag, +5 more
- Locations
-
- Shenzhen Second People's Hospital Shenzhen, Guangdong, China
Clinical trial condition
Cytopenia
Explore clinical trials studying Cytopenia. Study availability and eligibility vary by location and protocol.
1,007 public trials
191 recruiting studies
Cytopenia trial results
NCT04404608
- Conditions
- Cytopenia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- National Cancer Institute Cairo University Cairo, Egypt
Completed
Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.
NCT04914702
- Conditions
- Agranulocytosis, Chemotherapy-induced Neutropenia, Cytopenia, +9 more
- Locations
-
- University Children's Hospital Basel, University of Basel Basel, Switzerland
- Inselspital Bern, Switzerland
NCT05439265
- Conditions
- Blood Platelet Disorders, Cytopenia, Electronic Health Records, +4 more
- Locations
-
- Rush University Medical Center Chicago, Illinois, United States
NCT02279173
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Research Site Roseville, California, United States
- Research Site Atlanta, Georgia, United States
- Research Site Chicago, Illinois, United States
- Research Site Peoria, Illinois, United States
NCT05349383
- Conditions
- Agranulocytosis, Cytopenia, Hematologic Diseases, +11 more
- Locations
-
- Central South University Changsha, Hunan, China
NCT02922543
- Conditions
- Agranulocytosis, Arrhythmias, Cardiac, Blood Platelet Disorders, +55 more
- Locations
-
- Shinko Hospital Kobe, Hyōgo, Japan
NCT02921802
- Conditions
- Agranulocytosis, Arrhythmias, Cardiac, Blood Platelet Disorders, +57 more
- Locations
-
- Shinko Hospital Kobe, Hyōgo, Japan
- Conditions
- Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia, Agranulocytosis, Cytopenia, +5 more
- Locations
-
- Teva Investigational Site 32284 Aurich, Germany
- Teva Investigational Site 32314 Bad Soden am Taunus, Germany
- Teva Investigational Site 32267 Berlin, Germany
- Teva Investigational Site 32277 Berlin, Germany
NCT03429387
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Agranulocytosis, +23 more
- Locations
-
- Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
- Melbourne Health Parkville, Victoria, Australia